In the age of technology and information, medical innovation has taken a significant step in Romania, with the launch Diabeta, first medically approved chatbot by the National Agency for Medicines and Medical Devices ( ANMDM ). This innovative platform brings to the fore an innovative approach to diabetes management, ensuring access to accurate and verified information in real time.
DIABETA – A SOLUTION OPINION OF ANMDM
Diabeta is a medical chatbot that processes a vast base of information from official diabetes guides and protocols, as well as Characteristic Summaries of Products Used in the National Diabetes Program, to provide quick and accurate answers to questions about treatments available for diabetes. This high-tech platform has been developed to help doctors and health professionals, giving them the opportunity to easily access significant volumes of related professional data.
ACCESS INSTANT TO QUALITY INFORMATION
One of the particularly valuable aspects of Diabeta is that offer free access for health professionals, such as doctors and pharmacists. This facility supports those involved in diabetes management, providing them with a verified and rapid source of essential information to provide the best care for their patients. Access to Diabeta it is easy to obtain by a simple registration on the site www.diabeta.ro.
HOW DOES DIABETA WORK?
Doctors can access the platform Diabeta after authenticating with the previously assigned username and password. Once inside the platform, they have a chatbot interface that allows them to ask specific questions and receive answers instantly.
The response process is based on the extraction and analysis of information contained in official diabetes guides and protocols. Diabeta uses the latest data collection techniques, integrated with artificial intelligence algorithms, to provide reliable responses based on verified data. To ensure the accuracy of the information, the algorithm Diabeta was tested and validated by a team of renowned specialists in Romania.
PARTNERS ‘contribution AND EXPERTS TEAM
Development Diabeta it would not have been possible without the support and commitment of a dedicated team of professionals coordinated by associate professor dr. Anca Pantea Stoian. This innovative platform was created by the Romanian company Apollo AI Technologies, thus representing an example of innovation in the Romanian medical industry.
Diabeta also has the strong support of partners in the health industry, as well as Novo Nordisk, Boehringer Ingelheim and Medtronic, companies with a solid reputation in the medical field. This professional medical community is dedicated to providing quality medical information, transforming the way diabetes is approached and bringing benefits to both health professionals and their patients.
Diabeta is a remarkable advance in the management of diabetes and provides a reliable source of information for health professionals. With the help of artificial intelligence, this medical chatbot approved by ANMDM brings a new paradigm in the treatment of diabetes and proves to be a valuable resource for all those interested in providing the best care for patients with diabetes.
